It has been suggested that transplanted stem cells could overcome both Type 1 and Type 2 diabetes. However, as the success of a therapy is often judged by the degree of relief it gives to the patient, the final decision into whether stem cell-based treatments should be used depends on whether such therapies give a better quality of life than that offered by existing treatments such as exogenous insulin or, as in the case of type two diabetes, lifestyle changes.